Dihydrotanshinone I potentiates the anti-tumor activity of cisplatin by activating ROS-mediated ER stress through targeting HSPD1 in lung cancer cells

Haizhen Lin; Hehuan Sui; Ying Yu; Chenjun Xie; Yiwei Shen; Liyuan Cheng; Jiaying Wang; Yun Yu; Congying Xie; Ri Cui

doi:10.1016/j.ejphar.2025.177378

journal article May 01, 2025

Dihydrotanshinone I potentiates the anti-tumor activity of cisplatin by activating ROS-mediated ER stress through targeting HSPD1 in lung cancer cells

Haizhen Lin Hehuan Sui Ying Yu

Chenjun Xie Yiwei Shen Liyuan Cheng Jiaying Wang

Yun Yu

Congying Xie Ri Cui

European Journal of Pharmacology Vol. 994 pp. 177378 · Elsevier BV

View at Publisher Save 10.1016/j.ejphar.2025.177378

Topics

No keywords indexed for this article. Browse by subject →

References

50

[1]

Abu-Hadid "Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines" Cancer Lett. (1997) 10.1016/s0304-3835(97)00255-3

[2]

Aluksanasuwan "Potential association of HSPD1 with dysregulations in ribosome biogenesis and immune cell infiltration in lung adenocarcinoma: an integrated bioinformatic approach" Cancer Biomarkers : section A of Disease markers (2023) 10.3233/cbm-220442

[3]

Cao "Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020" Chinese medical journal (2021) 10.1097/cm9.0000000000001474

[4]

Chatterjee "Targeting heat shock proteins in cancer: a promising therapeutic approach" Int. J. Mol. Sci. (2017) 10.3390/ijms18091978

[5]

Cheng "Pendulone induces apoptosis via the ROS-mediated ER-stress pathway in human non-small cell lung cancer cells" Toxicol. Vitro : Int. J. Publ. Assoc. BIBRA (2022) 10.1016/j.tiv.2022.105346

[6]

Chuang "15,16-Dihydrotanshinone I, a compound of Salvia miltiorrhiza bunge, induces apoptosis through inducing endoplasmic reticular stress in human prostate carcinoma cells. Evidence-Based complementary and alternative medicine" eCAM (2011)

[7]

Coriat "Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo" Mol. Cancer Therapeut. (2012) 10.1158/1535-7163.mct-12-0093

[8]

Cisplatin in cancer therapy: Molecular mechanisms of action

Shaloam Dasari, Paul Bernard Tchounwou

European Journal of Pharmacology 2014 10.1016/j.ejphar.2014.07.025

[9]

Dubrez "Heat-shock proteins: chaperoning DNA repair" Oncogene (2020) 10.1038/s41388-019-1016-y

[10]

Fan "Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo" Cell Death Dis. (2020) 10.1038/s41419-020-2317-3

[11]

Fang "miR-382 contributes to renal tubulointerstitial fibrosis by downregulating HSPD1" Oxid. Med. Cell. Longev. (2017) 10.1155/2017/4708516

[12]

Fennell "Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer" Cancer Treat Rev. (2016) 10.1016/j.ctrv.2016.01.003

[13]

Fucarino "Role of HSP60/HSP10 in lung cancer: simple biomarkers or leading actors?" J. Oncol. (2020) 10.1155/2020/4701868

[14]

Ge "Toxic effects of Tripterygium glycoside tablets on the reproductive system of male rats by metabolomics, cytotoxicity, and molecular docking" Phytomedicine : Int. J. Phytother. Phytopharmacol. (2023) 10.1016/j.phymed.2023.154813

[15]

Gorrini "Modulation of oxidative stress as an anticancer strategy" Nat. Rev. Drug Discov. (2013) 10.1038/nrd4002

[16]

Groeger "Hydrogen peroxide as a cell-survival signaling molecule" Antioxidants Redox Signal. (2009) 10.1089/ars.2009.2728

[17]

Jiang "HIF-1α preconditioning potentiates antioxidant activity in ischemic injury: the role of sequential administration of dihydrotanshinone I and protocatechuic aldehyde in cardioprotection" Antioxidants Redox Signal. (2019) 10.1089/ars.2018.7624

[18]

Jones "Recent advances in the management of lung cancer" Clin. Med. (London, England) (2018) 10.7861/clinmedicine.18-2-s41

[19]

Kang "HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma" Sci. Rep. (2019) 10.1038/s41598-019-45489-1

[20]

Kashyap "Dihydrotanshinone-I modulates epithelial mesenchymal transition (EMT) thereby impairing migration and clonogenicity of triple negative breast cancer cells" Asian Pac. J. Cancer Prev. APJCP : Asian Pac. J. Cancer Prev. APJCP (2021) 10.31557/apjcp.2021.22.7.2177

[21]

Kim "Dihydrotanshinone-induced NOX5 activation inhibits breast cancer stem cell through the ROS/Stat3 signaling pathway" Oxid. Med. Cell. Longev. (2019) 10.1155/2019/9296439

[22]

Lin "Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response" Biomed.; Pharmacother. = Biomed.; Pharmacother. (2019)

[23]

Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis

Chunfeng Liu, Matjaz Rokavec, Zekai Huang et al.

Cell Death & Differentiation 2023 10.1038/s41418-023-01178-1

[24]

Lu "Lorlatinib for previously treated ALK-positive advanced NSCLC: primary efficacy and safety from a phase 2 study in people's Republic of China" J. Thorac. Oncol. : Off. Publ. Int. Assoc. Study of Lung Cancer (2022) 10.1016/j.jtho.2022.02.014

[25]

Makovec "Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy" Radiol. Oncol. (2019) 10.2478/raon-2019-0018

[26]

Matsuzawa "Stress-responsive protein kinases in redox-regulated apoptosis signaling" Antioxidants Redox Signal. (2005) 10.1089/ars.2005.7.472

[27]

Meng "Toward developing chemical modulators of Hsp60 as potential therapeutics" Front. Mol. Biosci. (2018) 10.3389/fmolb.2018.00035

[28]

Min "Heat shock protein 60 couples an oxidative stress-responsive p38/MK2 signaling and NF-κB survival machinery in cancer cells" Redox Biol. (2022) 10.1016/j.redox.2022.102293

[29]

Paithankar "Heavy metal associated health hazards: an interplay of oxidative stress and signal transduction" Chemosphere (2021) 10.1016/j.chemosphere.2020.128350

[30]

Parma "Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting" J. Exp. Clin. Cancer Res. (2021) 10.1186/s13046-021-02049-8

[31]

Perillo "ROS in cancer therapy: the bright side of the moon" Exp. Mol. Med. (2020) 10.1038/s12276-020-0384-2

[32]

Pizzino "Cadmium-induced oxidative stress impairs glycemic control in adolescents" Oxid. Med. Cell. Longev. (2017) 10.1155/2017/6341671

[33]

Qiu "Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020" Cancer Commun. (2021) 10.1002/cac2.12197

[34]

Shi "Identification of dihydrotanshinone I as an ERp57 inhibitor with anti-breast cancer properties via the UPR pathway" Biochem. Pharmacol. (2021) 10.1016/j.bcp.2021.114637

[35]

Srinivas "ROS and the DNA damage response in cancer" Redox Biol. (2019) 10.1016/j.redox.2018.101084

[36]

Sun "Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation" Free Radic. Biol. Med. (2022) 10.1016/j.freeradbiomed.2022.01.015

[37]

Sun "Nox4 promotes RANKL-induced autophagy and osteoclastogenesis via activating ROS/PERK/eIF-2α/ATF4 pathway" Front. Pharmacol. (2021) 10.3389/fphar.2021.751845

[38]

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al.

CA: A Cancer Journal for Clinicians 2021 10.3322/caac.21660

[39]

Tang "Down-regulation of HSP60 suppresses the proliferation of glioblastoma cells via the ROS/AMPK/mTOR pathway" Sci. Rep. (2016)

[40]

Trachootham "Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?" Nat. Rev. Drug Discov. (2009) 10.1038/nrd2803

[41]

Wang "The novel curcumin derivative 1g induces mitochondrial and ER-stress-dependent apoptosis in colon cancer cells by induction of ROS production" Front. Oncol. (2021)

[42]

Wang "Dihydrotanshinone induces p53-independent but ROS-dependent apoptosis in colon cancer cells" Life Sci. (2013) 10.1016/j.lfs.2013.07.007

[43]

Wang "New developments in the chemistry and biology of the bioactive constituents of Tanshen" Med. Res. Rev. (2007) 10.1002/med.20077

[44]

Wang "Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene" J. Cell Mol. Med. (2020) 10.1111/jcmm.15660

[45]

Wong "Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry" Oncol. Rep. (2008)

[46]

Wu "Heat shock proteins and cancer" Trends Pharmacol. Sci. (2017) 10.1016/j.tips.2016.11.009

[47]

Xu "Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1" Signal Transduct. Targeted Ther. (2023) 10.1038/s41392-022-01231-4

[48]

Xu "Heat shock protein-60 expression was significantly correlated with the prognosis of lung adenocarcinoma" J. Surg. Oncol. (2011) 10.1002/jso.21992

[49]

Yu "Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways" Phytomedicine (2022) 10.1016/j.phymed.2022.153932

[50]

Zhao "Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer" J. Transl. Med. (2022) 10.1186/s12967-022-03741-9

Cited By

7

RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications

Shanhe Huang, Zonglin Li · 2025

MedComm

Metrics

7

Citations

50

References

Details

Published: May 01, 2025
Vol/Issue: 994
Pages: 177378
License: View

Authors

University of Electronic Science and Technology of China

Funding

National Natural Science Foundation of China

Cite This Article

Haizhen Lin, Hehuan Sui, Ying Yu, et al. (2025). Dihydrotanshinone I potentiates the anti-tumor activity of cisplatin by activating ROS-mediated ER stress through targeting HSPD1 in lung cancer cells. European Journal of Pharmacology, 994, 177378. https://doi.org/10.1016/j.ejphar.2025.177378

Dihydrotanshinone I potentiates the anti-tumor activity of cisplatin by activating ROS-mediated ER stress through targeting HSPD1 in lung cancer cells

You May Also Like